PEI TAN: Open Payments
NPI 1851827893 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 91 payments from 16 companies in 2025. Trend: 2023 $1,176 · 2024 $1,402 · 2025 $2,169
Food & beverage: $2,131Education: $39
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $433 |
| Neurocrine BioSciences, Inc. | 12 | $371 |
| ABBVIE INC. | 15 | $240 |
| Janssen Pharmaceuticals, Inc | 3 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $152 |
| Vanda Pharmaceuticals Inc. | 5 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $117 |
| Supernus Pharmaceuticals, Inc. | 7 | $115 |
| Alkermes, Inc. | 3 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
Products named: INGREZZA, Auvelity, VRAYLAR, SPRAVATO, CAPLYTA, REXULTI, Sunosi, FANAPT.
Industry payments across GA — which companies pay providers there.
